抗霉菌预防对曲霉PCR血液检测诊断侵袭性曲霉病的影响
该研究基于22项队列研究、2912例侵袭性曲霉病(IA)风险患者的系统综述与荟萃分析,评估抗霉菌预防(AMP)对曲霉PCR血液检测准确性的影响。结果显示AMP不影响敏感性,但显著降低特异性:单次PCR阳性阈值下降低26%(P=0.005),≥2次连续阳性阈值下降低12%(P=0.019)。AMP组IA发生率(11%-12%)显著低于非AMP组(18%-19%)(P<0.001)。
要点
- 抗霉菌预防不改变曲霉PCR血液检测的敏感性。
- 抗霉菌预防显著降低曲霉PCR特异性,单次阳性阈值下降低26%。
- 接受预防者IA发生率(11%-12%)显著低于未接受者(18%-19%)。
核心结论
- 抗霉菌预防显著降低曲霉PCR血液检测特异性而不影响敏感性,与对GM-EIA的影响相反。
研究设计与样本
- 对22项队列研究、2912例IA风险患者进行系统综述与荟萃分析,按是否接受抗霉菌预防进行亚组分析。
主要发现
- 1661例(57%)患者接受预防,IA总发生率为14.2%。
- 预防组IA发生率(11%-12%)显著低于非预防组(18%-19%)(P<0.001)。
- 单次PCR阳性阈值下特异性降低26%(P=0.005),≥2次连续阳性阈值下降低12%(P=0.019)。
关键数值与推荐
- 单次PCR阳性结果阈值:特异性降低26%(P=0.005)。
- ≥2次连续PCR阳性结果阈值:特异性降低12%(P=0.019)。
临床怎么用
- 对接受抗霉菌预防的患者解读曲霉PCR阳性结果时需考虑特异性下降,避免过度诊断。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The performance of the galactomannan enzyme immunoassay (GM-EIA) is impaired in patients receiving mould-active antifungal therapy. The impact of mould-active antifungal therapy on Aspergillus PCR testing needs to be determined. OBJECTIVES: To determine the influence of anti-mould prophylaxis (AMP) on the performance of PCR blood testing to aid the diagnosis of proven/probable invasive aspergillosis (IA). METHODS: As part of the systematic review and meta-analysis of 22 cohort studies investigating Aspergillus PCR blood testing in 2912 patients at risk of IA, subgroup analysis was performed to determine the impact of AMP on the accuracy of Aspergillus PCR. The incidence of IA was calculated in patients receiving and not receiving AMP. The impact of two different positivity thresholds (requiring either a single PCR positive test result or ≥2 consecutive PCR positive test results) on accuracy was evaluated. Meta-analytical pooling of sensitivity and specificity was performed by logistic mixed-model regression. RESULTS: In total, 1661 (57%) patients received prophylaxis. The incidence of IA was 14.2%, significantly lower in the prophylaxis group (11%-12%) compared with the non-prophylaxis group (18%-19%) (P < 0.001). The use of AMP did not affect sensitivity, but significantly decreased specificity [single PCR positive result threshold: 26% reduction (P = 0.005); ≥2 consecutive PCR positive results threshold: 12% reduction (P = 0.019)]. CONCLUSIONS: Contrary to its influence on GM-EIA, AMP significantly decreases Aspergillus PCR specificity, without affecting sensitivity, possibly as a consequence of AMP limiting the clinical progression of IA and/or leading to false-negative GM-EIA results, preventing the classification of probable IA using the EORTC/MSGERC definitions.
引用
- Cruciani M, White PL, Mengoli C, et al. The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis. J Antimicrob Chemother. 2021. PMID: 33374010. doi:10.1093/jac/dkaa498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。